MetLife Investment Management’s Royalty Pharma RPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $234K | Sell |
|
|||||
|
2025
Q1 | $216K | Buy |
|
|||||
|
2024
Q4 | $175K | Buy |
|
|||||
|
2024
Q3 | $194K | Sell |
|
|||||
|
2024
Q2 | $185K | Sell |
|
|||||
|
2024
Q1 | $220K | Buy |
|
|||||
|
2023
Q4 | $203K | Sell |
|
|||||
|
2023
Q3 | $200K | Buy |
|
|||||
|
2023
Q2 | $226K | Sell |
|
|||||
|
2023
Q1 | $278K | Buy |
|
|||||
|
2022
Q4 | $304K | Buy |
|
|||||
|
2022
Q3 | $303K | Sell |
|
|||||
|
2022
Q2 | $325K | Sell |
|
|||||
|
2022
Q1 | $589K | Buy |
|